SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/02/21 Tenet Healthcare Corp. 8-K/A:5 1/07/21 11:175K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K/A Amendment to Current Report HTML 25K 7: R1 Document and Entity Information HTML 52K 9: XML IDEA XML File -- Filing Summary XML 12K 6: XML XBRL Instance -- d121875d8ka_htm XML 18K 8: EXCEL IDEA Workbook of Financial Reports XLSX 6K 3: EX-101.DEF XBRL Definitions -- thc-20210107_def XML 41K 4: EX-101.LAB XBRL Labels -- thc-20210107_lab XML 67K 5: EX-101.PRE XBRL Presentations -- thc-20210107_pre XML 43K 2: EX-101.SCH XBRL Schema -- thc-20210107 XSD 15K 10: JSON XBRL Instance as JSON Data -- MetaLinks 14± 22K 11: ZIP XBRL Zipped Folder -- 0001193125-21-065584-xbrl Zip 11K
8-K/A |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM i 8-K/A
Amendment No. 1
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report: i January 7, 2021 (Date of earliest event reported)
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
i Nevada | i 1-7293 | i 95-2557091 | ||
(State of Incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) |
i 14201 Dallas Parkway
i Dallas, i Texas i 75254
(Address of principal executive offices, including zip code)
i (469) i 893-2200
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading |
Name of each exchange | ||
i Common stock, $0.05 par value | i THC | i New York Stock Exchange | ||
i 6.875% Senior Notes due 2031 | i THC31 | i New York Stock Exchange |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging Growth Company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
i On January 8, 2021, Tenet Healthcare Corporation (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) to report that the Company’s Board of Directors (the “Board”) appointed Admiral Cecil D. Haney to the Board, effective on January 7, 2021. Admiral Haney had not yet been appointed to serve on any committees of the Board as of the Original Report. The Company is filing this amendment to the Original Report to report that, on February 24, 2021, the Board appointed Admiral Haney to serve as a member of the Board’s Audit Committee and Nominating and Corporate Governance Committee, effective immediately.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TENET HEALTHCARE CORPORATION | ||||||
Date: March 2, 2021 | ||||||
By: | /s/ Audrey Andrews | |||||
Name: | Audrey Andrews | |||||
Title: | Executive Vice President, General Counsel and Corporate Secretary |
This ‘8-K/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/2/21 | 4 | ||
2/24/21 | 4 | |||
1/8/21 | 8-K | |||
For Period end: | 1/7/21 | 3, 8-K | ||
List all Filings |